Your browser doesn't support javascript.
loading
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer.
Okuno, Keisuke; Kandimalla, Raju; Mendiola, Marta; Balaguer, Francesc; Bujanda, Luis; Fernandez-Martos, Carlos; Aparicio, Jorge; Feliu, Jaime; Tokunaga, Masanori; Kinugasa, Yusuke; Maurel, Joan; Goel, Ajay.
Afiliação
  • Okuno K; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, 1218 S. Fifth Avenue, Suite 2226, Monrovia, CA, 91016, USA.
  • Kandimalla R; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Mendiola M; Center for Gastrointestinal Research; Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute, Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA.
  • Balaguer F; Department of Medical Oncology, La Paz University Hospital (IdiPAZ), CIBERONC, cátedra UAM-AMGEN, Madrid, Spain.
  • Bujanda L; Department of Gastroenterology, Hospital Clinic de Barcelona, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Fernandez-Martos C; Department of Gastroenterology, Instituto Biodonostia, CIBERehd, Universidad del País Vasco (UPV/EHU), San Sebastián, Spain.
  • Aparicio J; Department of Medical Oncology, Hospital Quiron Salud, Valencia, Spain.
  • Feliu J; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Tokunaga M; Department of Medical Oncology, La Paz University Hospital (IdiPAZ), CIBERONC, cátedra UAM-AMGEN, Madrid, Spain.
  • Kinugasa Y; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Maurel J; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Goel A; Translational Genomics and Targeted Therapies Group. Medical Oncology, Hospital Clinic of Barcelona, CIBERehd, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Mol Cancer ; 22(1): 13, 2023 01 20.
Article em En | MEDLINE | ID: mdl-36670412
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / MicroRNAs Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / MicroRNAs Idioma: En Ano de publicação: 2023 Tipo de documento: Article